These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 901015)

  • 1. Toxicológical properties of diosmin and its actions on the isolated venous tissue of the dog.
    Heusser J; Osswald W
    Arch Farmacol Toxicol; 1977 Apr; 3(1):33-40. PubMed ID: 901015
    [No Abstract]   [Full Text] [Related]  

  • 2. The human saphenous vein in pharmacology: effect of a new micronized flavonoidic fraction (Daflon 500 mg) on norepinephrine induced contraction.
    Juteau N; Bakri F; Pomies JP; Foulon C; Rigaudy P; Pillion G; Lange G; Genre O; Cron JP
    Int Angiol; 1995 Sep; 14(3 Suppl 1):8-13. PubMed ID: 8919257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effect of tropolone and diosmin on venous COMT and sympathetic activity in rat.
    Boudet C; Peyrin L
    Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):312-20. PubMed ID: 3789890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diosmin therapy alters the in vitro metabolism of noradrenaline by the varicose human saphenous vein.
    Araujo D; Viana F; Osswald W
    Pharmacol Res; 1991 Oct; 24(3):253-6. PubMed ID: 1956869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg.
    Pascarella L; Lulic D; Penn AH; Alsaigh T; Lee J; Shin H; Kapur V; Bergan JJ; Schmid-Schönbein GW
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):102-10. PubMed ID: 17890112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract.
    Guillaume M; Padioleau F
    Arzneimittelforschung; 1994 Jan; 44(1):25-35. PubMed ID: 8135874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diosmin upon red blood cell deformability and osmotic fragility. Relationship with lipid content.
    Garnier M; Perret G; Pilardeau P; Vaysse J; Rolland Y; Uzzan B; Vassy R
    Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):259-62. PubMed ID: 3386333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A toxicological study of extractum hippocastani semen (EHS).
    Liehn HD; Franco PA; Hampel H; Hofrichter G
    Panminerva Med; 1972 Mar; 14(3):84-91. PubMed ID: 4681124
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination.
    Tanaka T; Makita H; Ohnishi M; Mori H; Satoh K; Hara A; Sumida T; Fukutani K; Tanaka T; Ogawa H
    Cancer Res; 1997 Jan; 57(2):246-52. PubMed ID: 9000563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lymphatic function of Daflon 500 mg.
    Labrid C
    Int Angiol; 1995 Sep; 14(3 Suppl 1):36-8. PubMed ID: 8919263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preclinical study of maxar safety].
    Saratikov AS; Livshits NS; Burchenkova FI; Kadychagova NG; Akhmedzhanov RR; Bashirova LV
    Eksp Klin Farmakol; 2003; 66(6):53-5. PubMed ID: 14743714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental methods for the detection of teratogens].
    Tuchmann-Duplessis H
    Biol Med (1971); 1974 Nov; 3(2):91-147. PubMed ID: 4620255
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic properties of Daflon 500 mg.
    Labrid C
    Angiology; 1994 Jun; 45(6 Pt 2):524-30. PubMed ID: 8203782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of vasoconstrictive potential of D-lysergic acid using an isolated bovine lateral saphenous vein bioassay.
    Klotz JL; Bush LP; Smith DL; Shafer WD; Smith LL; Vevoda AC; Craig AM; Arrington BC; Strickland JR
    J Anim Sci; 2006 Nov; 84(11):3167-75. PubMed ID: 17032812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid teratogenicity.
    Rowland JM; Hendrickx AG
    Adv Vet Sci Comp Med; 1983; 27():99-128. PubMed ID: 6359839
    [No Abstract]   [Full Text] [Related]  

  • 17. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity.
    Ciolino HP; Wang TT; Yeh GC
    Cancer Res; 1998 Jul; 58(13):2754-60. PubMed ID: 9661887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxicological study of some P factors].
    Radouco-Thomas S; Grumbach P; Nosal G; Garcin F
    Therapie; 1965; 20(4):879-88. PubMed ID: 5845205
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vasoconstrictor effects on isolated vessel segments determined by pressure-volume measurements].
    Weiss A; Koth W; Beer M; Glusa E; Markwardt F
    Biomed Biochim Acta; 1986; 45(10):1285-93. PubMed ID: 3566719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recording of the saphenous vein compliance by an ultrasonic echo-tracking device in the dog: effects of S 18149.
    Vayssettes-Courchay C; Cordi AA; Lacoste JM; Laubie M; Verbeuren TJ
    Br J Pharmacol; 1997 Dec; 122(7):1361-6. PubMed ID: 9421283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.